IDH1 and central nervous system cancer: Additionally, IDH R132H mutant cells display CpG island methylator phenotype, similarly to gliomas and acute myeloid leukemia, with reduced Tet1/2 activity (Figueroa et al., 2010; Turcan et al., 2012).